Farzin Roozafzai

976 total citations
10 papers, 37 citations indexed

About

Farzin Roozafzai is a scholar working on Endocrinology, Diabetes and Metabolism, Public Health, Environmental and Occupational Health and Surgery. According to data from OpenAlex, Farzin Roozafzai has authored 10 papers receiving a total of 37 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Endocrinology, Diabetes and Metabolism, 3 papers in Public Health, Environmental and Occupational Health and 2 papers in Surgery. Recurrent topics in Farzin Roozafzai's work include Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers), Health Promotion and Cardiovascular Prevention (3 papers) and Myofascial pain diagnosis and treatment (1 paper). Farzin Roozafzai is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers), Health Promotion and Cardiovascular Prevention (3 papers) and Myofascial pain diagnosis and treatment (1 paper). Farzin Roozafzai collaborates with scholars based in Iran and United Kingdom. Farzin Roozafzai's co-authors include Farhad Zamani, Samaneh Khorrami, Fahimeh Safarnezhad Tameshkel, Mansooreh Maadi, Fatemeh Sima Saeedian, Amir H. Faraji, Hossein Keyvani, Hossein Ajdarkosh, Behnam Rabiee and Hossein Poustchi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Public Health and Public Health.

In The Last Decade

Farzin Roozafzai

9 papers receiving 37 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Farzin Roozafzai Iran 5 12 8 7 7 6 10 37
Zoltán Nagy Hungary 4 17 1.4× 6 0.8× 9 1.3× 12 1.7× 3 0.5× 14 51
Anitha Devanath India 3 10 0.8× 11 1.4× 6 0.9× 4 0.6× 2 0.3× 9 24
Amirali Azimi Iran 5 14 1.2× 2 0.3× 3 0.4× 15 2.1× 2 0.3× 15 42
Marija Matašin Croatia 4 9 0.8× 4 0.5× 9 1.3× 23 3.3× 3 0.5× 13 36
Roberto Bleuel Amazonas Brazil 5 4 0.3× 3 0.4× 10 1.4× 10 1.4× 1 0.2× 7 46
Kirsty Pemberton United Kingdom 4 4 0.3× 18 2.3× 2 0.3× 8 1.1× 5 0.8× 6 65
Edward Charbek United States 6 8 0.7× 11 1.4× 2 0.3× 14 2.0× 17 80
Qingqing Zhang China 5 5 0.4× 3 0.4× 3 0.4× 6 0.9× 6 1.0× 11 54
Charles B. Eaton United States 2 16 1.3× 5 0.6× 2 0.3× 5 0.7× 8 1.3× 5 36
Balaji Rajagopalan India 4 4 0.3× 18 2.3× 2 0.3× 6 0.9× 3 0.5× 10 32

Countries citing papers authored by Farzin Roozafzai

Since Specialization
Citations

This map shows the geographic impact of Farzin Roozafzai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farzin Roozafzai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farzin Roozafzai more than expected).

Fields of papers citing papers by Farzin Roozafzai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farzin Roozafzai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farzin Roozafzai. The network helps show where Farzin Roozafzai may publish in the future.

Co-authorship network of co-authors of Farzin Roozafzai

This figure shows the co-authorship network connecting the top 25 collaborators of Farzin Roozafzai. A scholar is included among the top collaborators of Farzin Roozafzai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farzin Roozafzai. Farzin Roozafzai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Roozafzai, Farzin, et al.. (2025). Predictors of 12-Month Recurrence of Hemoptysis after Bronchial Artery Embolization. Archives of Iranian Medicine. 28(2). 100–106.
2.
Amini, Kumarss, et al.. (2023). Expression of MicroRNA-155 in Patients with Non-Hodgkin Lymphoma, Coronavirus Disease 2019, or Both: A Cross-Sectional Study.. SHILAP Revista de lepidopterología. 48(1). 26–34. 4 indexed citations
3.
Darvishian, Maryam, Maryam Sharafkhah, Zahra Mohammadi, et al.. (2022). SARS-CoV-2 Seroprevalence Among Health Care Workers in Major Private and Public Hospitals With COVID-19 Patient's Referral in Tehran, Iran. Frontiers in Public Health. 10. 832003–832003. 1 indexed citations
4.
Motamed, Nima, Farzin Roozafzai, Mahmoodreza Khoonsari, et al.. (2022). Predictive ability of six obesity measures to identify 7-year fatal and non-fatal cardiovascular events: A population-based cohort study. International Journal of Cardiology Cardiovascular Risk and Prevention. 14. 200142–200142. 2 indexed citations
5.
Motamed, Nima, G. Hossein Ashrafi, Fahimeh Safarnezhad Tameshkel, et al.. (2021). Comparison of risk assessment tools for cardiovascular diseases: results of an Iranian cohort study. Public Health. 200. 116–123. 1 indexed citations
6.
Roozafzai, Farzin, et al.. (2020). Citrullus colocynthis: the Most Suggested Herb in Persian Medicine for Management of Low-Back Pain. SHILAP Revista de lepidopterología. 7(1). 79–86. 2 indexed citations
7.
Roozafzai, Farzin, et al.. (2020). Persian manual therapy method for chronic low-back pain with lumbar radiculopathy; a randomized controlled trial. Journal of Bodywork and Movement Therapies. 24(3). 123–130. 4 indexed citations
8.
Tameshkel, Fahimeh Safarnezhad, et al.. (2018). The Evaluation of Diagnostic and Predictive Values of Helicobacter pylori Stool Antigen Test in Iranian Patients with Dyspepsia. Iranian journal of pathology. 13(1). 39–44. 10 indexed citations
9.
Rabiee, Behnam, Farzin Roozafzai, Hossein Poustchi, et al.. (2017). The Prevalence of Non-alcoholic Fatty Liver Disease and Diabetes Mellitus in an Iranian Population. Middle East Journal of Digestive Diseases. 9(2). 86–93. 7 indexed citations
10.
Rabiee, Behnam, Farzin Roozafzai, Farhad Zamani, et al.. (2017). Metabolic syndrome and cardiovascular risk assessment tools’ estimations of 10-year cardiovascular risk: a population-based study. Acta cardiologica. Supplementum. 73(5). 439–446. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026